Acorah Software Products - Accounts Production 15.0.600 false true 31 May 2023 1 June 2022 false true No description of principal activity 1 June 2023 31 May 2024 31 May 2024 12026489 Dr Bridget King iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 12026489 2023-05-31 12026489 2024-05-31 12026489 2023-06-01 2024-05-31 12026489 frs-core:CurrentFinancialInstruments 2024-05-31 12026489 frs-bus:PrivateLimitedCompanyLtd 2023-06-01 2024-05-31 12026489 frs-bus:FilletedAccounts 2023-06-01 2024-05-31 12026489 frs-bus:Micro-entities 2023-06-01 2024-05-31 12026489 frs-bus:AuditExempt-NoAccountantsReport 2023-06-01 2024-05-31 12026489 frs-bus:Director1 2023-06-01 2024-05-31 12026489 2022-05-31 12026489 2023-05-31 12026489 2022-06-01 2023-05-31 12026489 frs-core:CurrentFinancialInstruments 2023-05-31
Registered number: 12026489
Bjk Pharma Consulting Ltd
Unaudited Financial Statements
For The Year Ended 31 May 2024
Balance Sheet
Registered number: 12026489
2024 2023
£ £
Current assets 103,619 71,305
Prepayments and accrued income 401 16,608
Creditors: Amounts Falling Due Within One Year (80,532 ) (43,500 )
NET CURRENT ASSETS 23,488 44,413
TOTAL ASSETS LESS CURRENT LIABILITIES 23,488 44,413
NET ASSETS 23,488 44,413
CAPITAL AND RESERVES 23,488 44,413

Notes

1. General Information
Bjk Pharma Consulting Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 12026489 . The registered office is Belmont Suite Paragon Business Park, Chorley New Road, Horwich, Bolton, BL6 6HG.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2023: 1)
1 1
For the year ending 31 May 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Dr Bridget King
Director
08/09/2024